Regulations.gov document
Patient Counseling Information Section of Labeling for Human Prescription Drug and…
Notice · FDA-2013-D-1067 · posted Dec 10, 2014
Key facts
| Document ID | FDA-2013-D-1067-0004 |
|---|---|
| Title | Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products--Content and Format; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2013-D-1067 |
| Posted | Dec 10, 2014 |
| Federal Register citation | FR 79 73322 |
| FR document number | 2014-28888 |
| Comment period opens | Dec 10, 2014 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: